JESSICA STRICKLAND: Open Payments
NPI 1063968055 · AYNOR, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 32 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 5 | $259 |
| AstraZeneca Pharmaceuticals LP | 10 | $190 |
| Novo Nordisk Inc | 3 | $88 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| ABBVIE INC. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Lilly USA, LLC | 2 | $32 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $18 |
Products named: VOQUEZNA, AIRSUPRA, FARXIGA, Wegovy, TRELEGY ELLIPTA, CAPLYTA, VRAYLAR, QULIPTA.
Industry payments across SC — which companies pay providers there.
